14:09:16 EST Sat 15 Nov 2025
Enter Symbol
or Name
USA
CA



Delphx Capital Markets Inc
Symbol DELX
Shares Issued 209,850,183
Close 2025-11-14 C$ 0.04
Market Cap C$ 8,394,007
Recent Sedar Documents

Delphx closes $60,000 private placement

2025-11-14 18:17 ET - News Release

Mr. George Wentworth reports

DELPHX ANNOUNCES CLOSING OF NON-BROKERED UNIT PRIVATE PLACEMENT

Delphx Capital Markets Inc. has closed its non-brokered private placement previously announced on Nov. 12, 2025, issuing 1.2 million units at a subscription price of five cents per unit, for gross proceeds of $60,000. Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share at a price of eight cents for a period of two years from the date of issuance.

Completion of the offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the offering will be subject to a hold period of four months plus one day from the date of issuance.

Delphx intends to use the net proceeds from the offering in connection with general corporate purposes.

About Delphx Capital Markets Inc.

Delphx is a technology and financial service company focused on developing and distributing the next generation of structured products. Through its special-purpose vehicle Quantem LLC, the company enables broker dealers to offer new private placement securities that provide for both fixed-income and cryptocurrency solutions. The new Delphx securities will enable dealers and their qualified institutional investors accounts to competitively structure, sell and make markets in:

  • Collateralized put options that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
  • Collateralized reference notes that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by U.S. Bank. CPOs and CRNs are proprietary products created and owned by Delphx Capital Markets.

© 2025 Canjex Publishing Ltd. All rights reserved.